Centers for Medicare & Medicaid Services www.cms.gov www.medicaid.gov www.medicare.gov COVID-19: Long-term Care, Remdesivir, & Booster Doses Centers for Medicare & Medicaid Services (CMS) sent this bulletin at 01/13/2022 11:00 AM EST CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) Thursday, January 13, 2022 News COVID-19: Updated Materials for Visiting Nursing Homes During Omicron Surge COVID-19: Vaccine Access in Long-term Care Settings COVID-19: New HCPCS Code for Remdesivir Antiviral Medication – Updated NIH Treatment Guidelines Panel Link COVID-19: Pfizer Booster Doses for Ages 12+ & Immunocompromised Ages 5–11 CMS Proposes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease & National Stakeholder Call Additional Residency Positions: Apply by March 31 Medicare Ground Ambulance Data Collection System: Updated Documents DMEPOS Requirement Updates Effective April 13 RHC: AIR Payment Limit for CY 2022 Non-Medical Factors Can Affect Patient Health Compliance DMEPOS Items: Documenting Medical Records Claims, Pricers, & Codes DMEPOS: Accreditation Claims Edits Events National Stakeholder Call with the CMS Administrator — January 18 Publications Clinical Lab Fee Schedule — Revised View the full edition Report a problem viewing this newsletter. The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registeredtrademarks of the U.S. Department of Health and Human Services (HHS). Paid for by HHS.